Patricia Acton ⎜Sep 5, 2018 ⎜ Calendar
isoSolutions will be attending the United Pharmacy Partners (UPPI, LLC) 2018 Annual Meeting to be held in San Antonio, TX September 12 to 15, 2018. (more…)
Tags: Batch Reporting System Beta detection Beta flow monitor Beta radio-detector Cassette-based synthesis Chromatography Software Clarity Elysia-raytest Ga-68 synthesis Gamma detection Gamma flow monitor Gamma radio-detector Gamma spectroscopy Gas Chromatography GC systems HPLC isoSolutions LIMS Liquid Scintillation Liquid Scintillation Pump Lu-177 MCA Multichannel analyzer North America Nuclear Medicine PET QC QC-Cubicle Quality Control Radio Detector Radio nuclide identification Radio nuclide purity radio spectroscopy radio TLC scanners radio-flow monitor radio-HPLC radio-synthesis radio-TLC Systems Radio-tracer Radiopharmaceutical Tracer Radiopharmaceuticals Radiopharmacy Residual Solvents Control Single-use cassette synthesis SPECT QC Spectroscopy Software Sterile filter integrity test Sterility Filter Test Synthesis Modules Synthesizers Tradeshows UPPI
Kevin Yang ⎜Mar 20, 2018 ⎜ Industry
99mTc-sestamibi CZT-SPECT is technically feasible and can provide similar result to 15O-water PET for detecting impaired myocardial flow reserve and abnormal fractional flow reserve in patients with coronary artery disease. This study highlights the diagnostic value of using 99mTc -sestamibi for patients with coronary artery disease.
The WATERDAY study: Denis Agostini & Vincent (more…)
Kevin Yang ⎜Mar 12, 2018 ⎜ Industry
Osteoclast activity is an important factor in the pathogenesis of skeletal metastases and is a potential therapeutic target. This study aimed to determine if selective uptake of 99mTc-maraciclatide, a radiopharmaceutical targeting αvβ3 integrin, occurs in prostate cancer (PCa) bone metastases and to observe the changes following systemic therapy. (more…)
David T. Drummond ⎜Oct 24, 2017 ⎜ Company
“Vancouver, BC – The Western Region Society of Nuclear Medicine (WRSNM) will honor Dr. François Bénard from the BC Cancer Agency with the presentation of their Distinguished Scientist Award. … Dr. Bénard is the Vice President, Research at the BC Cancer Agency, a Distinguished Scientist at the BC Cancer Agency Research Centre and Professor in the Department of Radiology at the University of British Columbia. He is also Associate Dean, Research at the University of British Columbia. In addition he holds the BC Leadership Chair in Functional Cancer Imaging. As a clinician scientist, his research interests are in positron emission tomography (PET), nuclear medicine, cancer imaging and targeted radionuclide therapy. (more…)
David T. Drummond ⎜Nov 15, 2016 ⎜ Products
Fast implementation of positron emission tomography (PET) into clinical and preclinical studies highly demands automated synthesis for the preparation of PET radiopharmaceuticals in a safe and reproducible manner. The aim of this study was to develop automated synthesis methods for these six 18F-labeled radiopharmaceuticals produced on a routine basis at the University of Pennsylvania using (more…)
David T. Drummond ⎜Sep 24, 2016 ⎜ Products
ln produced on a routine basis at UPENN with the Trasis AllinOne synthesizer.
By Ramona Delcea, Trasis Download pdf